This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Adjusting your budget mid month can be simple. Explore these quick tips to make the process easier.
22,217 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Prentice Capital has exited its Compass position, reporting a zero stake after the latest quarter. This move highligh...
Iran issues largest-ever currency note as inflation accelerates and cash demand climbs. The move highlights a liquidi...
Better Home & Finance and Coinbase rolled out a crypto-backed conforming mortgage option that lets qualified borrower...
Bitcoin held near $80,000 as oil rose and the dollar strengthened, signaling a possible self-driven pull in BTC beyon...
Investors are buzzing about Uber stock soaring? as the company moves toward stronger profitability and disciplined gr...
Apple and Microsoft posted strong earnings as the AI battle tightens. Microsoft leads on monetizing generative AI, wh...
India tightened gold import rules this week, a move officials say protects the rupee, but traders warn it could bolst...
ShoreHaven Wealth Partners is shifting focus from a U.S.-centric mix to international exposure via an active rotation...
Latin America's fintech leaders have faced a choppy earnings season, but patient investors see potential. This guide ...
A transformative bid, a larger regulated footprint, and a path to AI-era resilience. Explore how NextEra Energy's Dom...
A seasoned fund trimmed a big winner after a meteoric run. This article breaks down the why behind the move, the numb...